Modulation of pRb/E2F functions in the regulation of cell cycle and in cancer

Current Cancer Drug Targets

Volumn 5, Issue 3, 2005, Pages 159-170

  Seville, Lucy L ^a   Shah, Nita ^a   Westwell, Andrew D ^a   Chan, Weng C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARQ 501; BETA LAPACHONE; CYCLIN DEPENDENT KINASE; CYCLINE; DOCETAXEL; GEMCITABINE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; CANCER; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL TRIAL; DRUG TARGETING; HUMAN; MITOSIS; MOLECULAR BIOLOGY; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; DNA DAMAGE; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, MOLECULAR; NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 18844454573     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009053765816     Document Type: Review

References (69)

1. Lodish, H.; Berk, A.; Matsudaira, P.; Kaiser, C. A.; Krieger, M.; Scott, M. P.; Zipursky, S. L.; Darnell, J. Mol. Cell Biol. 2003, 5th Ed.; W. H. Freeman and Company, New York.
2. Weinberg, R. A. The retinoblastoma protein and cell-cycle control. Cell 1995, 81, 323-330.
3. Thomas, N. S. B. Apoptosis and Cell Cycle Control in Cancer 1996, 1st Ed.; BIOS Scientific Publishers Ltd., UK.
4. Harbour, J. W.; Dean, D. C. Rb function in cell-cycle regulation and apoptosis. Nat. Cell Biol. 2000, 2, E65-E67.
5. Kovesdi, I.; Reichel, R.; Nevins, J. R. Identification of a cellular transcription factor involved in E1A transactivation. Cell 1986, 45, 219-228.
6. Wyllie, A. H. E2F1 selects tumour cells for both life and death. J. Pathol. 2002, 198, 139-141.
7. Nahle, Z.; Polakoff, J.; Davuluri, R. V.; McCurrach, M. E.; Jacobson, M. D.; Narita, M.; Zhang, M. Q.; Lazebnik, Y.; Bar-Sagi, D.; Lowe, S. W. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 2002, 4, 859-864.
8. Ma, D. D.; Zhou, P.; Harbour, J. W. Distinct mechanisms for regulating the tumor suppressor and antiapoptotic functions of Rb. J. Biol. Chem. 2003, 278, 19358-19366.
9. Johnson, D. G.; Schneider-Broussard, R. Role of E2F in cell cycle control and cancer. Front. Biosci. 1998, 3, D447-D448.
10. Nevins, J. R. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 2001, 10, 699-703.
11. Friend, S. H.; Bernards, R.; Rogelj, S.; Weinberg, R. A.; Rapaport, J. M.; Albert, D. M.; Dryja, T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986, 323, 643-646.
12. Ross, J. F.; Liu, X.; Dynlacht, B. D. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol. Cell 1999, 3, 195-205.
13. Girling, R.; Partridge, J. F.; Bandara, L. R.; Burden, N.; Totty, N. F.; Hsuan, J. J.; La Thangue, N. B. A new component of the transcription factor DRTF1/E2F. Nature 1993, 362, 83-87.
14. Bracken, A. P.; Ciro, M.; Cocito, A.; Helin, K. E2F target genes: Unraveling the biology. Trends Biochem. Sci. 2004, 29, 409-417.
15. de Bruin, A.; Maiti, B.; Jakoi, L.; Timmers, C.; Buerki, R.; Leone, G. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. J. Biol. Chem. 2003, 278, 42041-42049.
16. Di Stefano, L.; Jenson, M. R.; Helin, K. E2F-7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J. 2003, 22, 6289-6298.
17. Classon, M.; Harlow, E. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer 2002, 2, 910-917.
18. Gaubatz, S.; Wood, J. G.; Livingston, D. M. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl. Acad. Sci. USA 1998, 95, 9190-9195.
19. Ogawa, H.; Ishiguro, K.; Gaubatz, S.; Livingston, D. M.; Nakatani, Y. A complex with chromatin modifiers that occupies E2F-and Myc- responsive genes in G(0) cells. Science 2002, 296, 1132-1136.
20. Trimarchi, J. M.; Fairchild, B.; Wen, J.; Lees, J. A. The E2F-6 transcription factor is a component of the mammalian BMI1-containing polycomb complex. Proc. Natl. Acad. Sci. USA 2001, 98, 1519-1524.
21. Blais, A.; Dynlacht, B. D. Hitting their targets: an emerging picture of E2F and cell cycle control. Curr. Opin. Genet. Dev. 2004, 14, 527-532.
22. Helin, K.; Lees, J. A.; Vidal, M.; Dyson, N.; Harlow, E.; Fattaey, A. A CDNA-encoding a pRb-binding protein with properties of the transcription factor E2F. Cell 1992, 70, 337-350.
23. Lee, J. O.; Russo, A. A.; Pavletich, N. P. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 1998, 391, 859-865.
24. Lee, C.; Chang, J. H.; Lee, H. S.; Cho, Y. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumour suppressor. Genes Dev. 2002, 3199-3212.
25. Xiao, B.; Spencer, J.; Clements, A.; Ali-Khan, N.; Mittnacht, S.; Broceno, C.; Burghammer, M.; Perrakis, A.; Marmorstein, R.; Gamblin, S. J. Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation. Proc. Natl. Acad. Sci. USA 2003, 100, 2363-2368.
26. Shan, B.; Durfee, T.; Lee, W. H. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl. Acad. Sci. USA 1996, 93, 679-684.
27. Qin, X. Q.; Chittenden, T.; Livingston, D. M.; Kaelin, W. G. Identification of a growth suppression domain within the retinoblastoma gene-product. Genes Dev. 1992, 6, 953-964.
28. Dick, F. A.; Dyson, N. pRB contains an E2F1-specific binding domain that allows E2F1- induced apoptosis to be regulated separately from other E2F activities. Mol. Cell 2003, 12, 639-649.
29. Chellappan, S.; Kraus, V. B.; Kroger, B.; Munger, K.; Howley, P. M.; Phelps, W. C.; Nevins, J. R. Adenovirus-E1A, simian virus-40 tumor-antigen, and human papillomavirus-E7 protein share the capacity to disrupt the interaction between transcription factor-E2F and the retinoblastoma gene-product. Proc. Natl. Acad. Sci. USA 1992, 89, 4549-4553.
30. Decaprio, J. A.; Ludlow, J. W.; Figge, J.; Shew, J. Y.; Huang, C. M.; Lee, W. H.; Marsilio, E.; Paucha, E.; Livingston, D. M. Sv40 large tumor-antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988, 54, 275-283.
31. Whyte, P.; Buchkovich, K. J.; Horowitz, J. M.; Friend, S. H.; Raybuck, M.; Weinberg, R. A.; Harlow, E. Association between an oncogene and an anti-oncogene - the adenovirus E1A proteins bind to the retinoblastoma gene-product. Nature 1988, 334, 124-129.
32. Fattaey, A. R.; Harlow, E.; Helin, K. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol. Cell Biol. 1993, 13, 7267-7277.
33. Brehm, A.; Miska, E. A.; McCance, D. J.; Reid, J. L.; Bannister, A. J.; Kouzarides, T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998, 391, 597-601.
34. Chau, B. N.; Wang, J. Y. J. Coordinated regulation of life and death by Rb. Nat. Rev. Cancer 2003, 3, 130-138.
35. Takaki, T.; Fukasawa, K.; Suzuki-Takahashi, I.; Hirai, H. CDK-mediated phosphorylation of pRB regulates HDAC binding in vitro. Biochem. Biophys. Res. Comm. 2004, 316, 252-255.
36. Barrie, S. E.; Eno-Amooquaye, E.; Hardcastle, A.; Platt, G.; Richards, J.; Bedford, D.; Workman, P.; Aherne, W.; Mittnacht, S.; Garrett, M. D. High-throughput screening for the identification of small- molecule inhibitors of retinoblastoma protein phosphorylation in cells. Anal. Biochem. 2003, 320, 66-74.
37. Harbour, J. W.; Luo, R. X.; Santi, A. D.; Postigo, A. A.; Dean, D. C. CDK phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999, 98, 859-869.
38. Adams, P. D.; Li, X. T.; Sellers, W. R.; Baker, K. B.; Leng, X. H.; Harper, J. W.; Taya, Y.; Kaelin, W. G. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin:CDK complexes. Mol. Cell Biol. 1999, 19, 1068-1080.
39. Geng, Y.; Whoriskey, W.; Park, M. Y.; Bronson, R. T.; Medema, R. H.; Li, T. S.; Weinberg, R. A.; Sicinski, P. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 1999, 97, 767-777.
40. Dick, F. A.; Dyson, N. J. Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins. J. Virol. 2002, 76, 6224-6234.
41. INK4a-Rb pathway by promoting nuclear export of E2F4/5. J. Cell Biol. 2003, 162, 173-183.
42. Kau, T. R.; Way, J. C.; Silver, P. A. Nuclear transport and cancer: From mechanism to intervention. Nat. Rev. Cancer 2004, 4, 1-12.
43. Tan, X. Q.; Wang, J. Y. J. The caspase-Rb connection in cell death. Trends Cell Biol. 1998, 8, 116-120.
44. Sharp, T. V.; Munoz, F.; Bourboulia, D.; Presneau, N.; Darai, E.; Wang, H. W.; Cannon, M.; Butcher, D. N.; Nicholson, A. G.; Klein, G.; Imreh, S.; Boshoff, C. LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRb and represses E2F-driven transcription. Proc. Natl. Acad. Sci. USA 2004, 101, 16531-16536.
45. Flemington, E. K.; Speck, S. H.; Kaelin, W. G. E2F-1-mediated transactivation is inhibited by complex- formation with the retinoblastoma susceptibility gene-product. Proc. Natl. Acad. Sci. USA 1993, 90, 6914-6918.
46. Harbour, J. W.; Dean, D. C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 2000, 14, 2393-2409.
47. Kingston, R. E.; Narlikar, G. J. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. 1999, 13, 2339-2352.
48. Luo, R. X.; Postigo, A. A.; Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell 1998, 92, 463-473.
49. Tyler, J. K.; Kadonaga, J. T. The "dark side" of chromatin remodeling: Repressive effects on transcription. Cell 1999, 99, 443-446.
50. Barrera, G.; Pizzimenti, S.; Dianzani, M. U. 4-Hydroxynonenal and regulation of cell cycle: Effects on the pRb/E2F pathway. Free Radic. Biol. Med. 2004, 37, 597-606.
51. Stevens, C.; La Thangue, N. B. The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair 2004, 3, 1071-1079.
52. Pan, H. C.; Yin, C. Y.; Dyson, N. J.; Harlow, E.; Yamasaki, L.; Van Dyke, T. Key roles for E2F-1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol. Cell 1998, 2, 283-292.
53. Bates, S.; Phillips, A. C.; Clark, P. A.; Statt, F.; Peters, G.; Ludwig, R. L.; Vousden, K. H. p14(ARF) links the tumour suppressors Rb and p53. Nature 1998, 395, 124-125.
54. Irwin, M.; Marin, M. C.; Phillips, A. C.; Seelan, R. S.; Smith, D. I.; Liu, W. G.; Flores, E. R.; Tsai, K. Y.; Jacks, T.; Vousden, K. H.; Kaelin, W. G. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000, 407, 645-648.
55. Moroni, M. C.; Hickman, E. S.; Denchi, E. L.; Caprara, G.; Colli, E.; Cecconi, F.; Muller, H.; Helin, K. Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 2001, 3, 552-558.
56. Phillips, A. C.; Ernst, M. K.; Bates, S.; Rice, N. R.; Vousden, K. H. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol. Cell 1999, 4, 771-781.
57. Karin, M.; Lin, A. NF-kappa B at the crossroads of life and death. Nat. Immunol. 2002, 3, 221-227.
58. Darnell, J. E. Transcription Factors as Targets for Cancer Therapy. Nat. Rev. Cancer 2002, 2, 740-749.
59. Macleod, K. F.; Hu, Y. W.; Jacks, T. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 1996, 15, 6178-6188.
60. Trimarchi, J. M.; Lees, J. A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 2002, 3, 11-20.
61. Wells, J.; Boyd, K. E.; Fry, C. J.; Bartley, S. M.; Farnham, P. J. Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell Biol. 2000, 20, 5797-5807.
62. Pediconi, N.; Ianari, A.; Costanzo, A.; Belloni, L.; Gallo, R., Cimino, L.; Porcellini, A.; Screpanti, I.; Balsano, C.; Alesse, E.; Gulino, A.; Levrero, M. Differential regulation of E2F-1 apoptotic target genes in response to DNA damage. Nat. Cell Biol. 2003, 5, 552-558.
63. Blattner, C.; Sparks, A.; Lane, D. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Mol. Cell Biol. 1999, 19, 3704-3713.
64. La Thangue, N. B. The yin and yang of E2F-1: Balancing life and death. Nat. Cell Biol. 2003, 5, 587-589.
65. Gorgoulis, V. G.; Zacharatos, P.; Mariatos, G.; Kotsinas, A.; Bouda, M.; Kletsas, D.; Asimacopoulos, P. J.; Agnantis, N.; Kittas, C.; Papavassiliou, A. G. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J. Pathol. 2002, 198, 142-156.
66. Zacharatos, P.; Kotsinas, A.; Evangelou, K.; Karakaidos, P.; Vassiliou, L. V.; Rezaei, N.; Kyroudi, A.; Kittas, C.; Patsouris, E.; Papavassiliou, A. G.; Gorgoulis, V. G. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas. J. Pathol. 2004, 203, 744-753.
67. Onda, M.; Nagai, H.; Yoshida, A.; Miyamoto, S.; Asaka, S.; Akaishi, J.; Takatsu, K.; Nagahama, M.; Ito, K.; Shimizu, K.; Emi, M. Up-regulation of transcriptional factor E2F-1 in papillary and anaplastic thyroid cancers. J. Hum. Genet. 2004, 49, 312-318.
68. Li, Y. Z.; Sun, X. G.; LaMont, J. T.; Pardee, A. B.; Li, C. J. Selective killing of cancer cells by beta-lapachone: Direct checkpoint activation as a strategy against cancer. Proc. Natl. Acad. Sci. USA 2003, 100, 2674-2678.
69. http://www.fdanews.com/dailies/dpa/2_194/news/30249-9.html 31/10/04.